LEI 875500TUDYQK1M7YRP43
ExeVir Bio
Contract awards & public grants
ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2 → EXEVIR BIO
European Commission · BE · Grant · 2021-11-15
€6.56M
ExeVir Bio — Besluit O&O Kennisintensief
VLAIO (Flanders Innovation & Entrepreneurship) · BE · Grant · 2021-03-18
€2.96M
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.